Is is fanastic to see that Ryeqo (relugolix, estradiol, norethisterone acetate) has been added to the Australian Pharmaceutical Benefits Scheme (PBS) as of 1 May 2025.

This tablet taken daily, helps to reduce the pain of symptomatic endometriosis in moderate to severe endometriosis.

This will help reduce the annual cost of this medication from up to $2500 down to $100-380 per year. 

Key Information

  • Indication: For women with moderate to severe endometriosis‑related pain who have previously tried medical or surgical treatment.
  • How it works: Suppresses ovarian function to reduce pain and bleeding.
  • Convenience: A once‑daily tablet that also provides contraceptive protection.
  • Eligibility: Considered a second‑line treatment when first‑line options have not provided adequate relief.

For further information, please see this link https://www1.racgp.org.au/newsgp/clinical/what-is-ryeqo

Dr Leong is a senior consultant with Monash IVF, Obstetrician and Gynaecologist at Epworth Richmond. Born in Malaysia, Dr Leong moved to Australia with his parents at a young age. As a Monash University graduate, Dr Leong is involved in teaching gynaecologist trainees in laparoscopic surgery and mentors medical students during their undergraduate years from Monash University. Dr Leong is a regular guest speaker at GP lecture series with Monash IVF discussing topics like egg freezing, combined factor infertility, do you really need IVF?, endometriosis, uterine fibroids, sperm donors and more. Dr Leong also consults at Box Hill (Ekera Medical Centre). He consults in English, Mandarin, Cantonese and Bahasa Malaysia. 

Back to top